Table 1

Suggested diagnosis and if additional diagnostic IHC staining would be ordered by 20 pathologists for 52 unselected bronchial and lung biopsies based on H&E, p40 and TTF-1 (clone SPT24) staining (the reference diagnosis, and if additional IHC staining was performed and used for diagnostics, is marked in grey)

CaseSuggested diagnosisAdditional IHC*
ACSqCCSCLCNSCC probably LCNECCTNSCC otherNSCC NOSNon-epithelial malignancyMetastasisSuspect malignancyUnclear atypiaBenign/Non-neoplasticNo replyYesNo
1173712
220163
3†51176811
4‡3281141181
5181110
6119181
762192181
81055163
97310712
10181112§7
1120163
1220190
135258181
1412161172
15181112
1611117712
1719115
181181154
1920316
20389613
211631109
2220190
23¶1811811
24†122213118
2520118
2651293172
27119217
281118415
292117190
30182316
31191181
32191019
332171190
34**8146113§6
351622811
361118217
371811316
38721541145
394214109
40†1721613
41¶8273181
421811172
4312122311
4441375118
45211133109
461811613
471721613
48¶7121136
492315181
501118316
5132141613
52††614190
  • *One pathologist did not state if additional IHC would be ordered.

  • †Follow-up sample showed AC/NSCC.

  • ‡Considered mixed SCLC/LCNEC by the reference standard.

  • §Given the morphology and results of p40 and TTF-1, the additional IHC stainings were not necessary for the reference diagnosis.

  • ¶LCNEC/carcinoid diagnosis was confirmed on resection.

  • **Focal sarcomatoid features.

  • ††Despite comprehensive analyses not perfectly clear if lung cancer or recurrent breast cancer.

  • AC, adenocarcinoma; CT, carcinoid tumour; IHC, immunohistochemistry; LCNEC, large cell neuroendocrine carcinoma; NSCC NOS, non-small cell carcinoma not otherwise specified; NSCC, non-small cell carcinoma; SCLC, small cell lung carcinoma; SqCC, squamous cell carcinoma; TTF-1, thyroid transcription factor-1.